On May 30, 2019 PureTech Health plc (LSE: PRTC) ("PureTech Health"), an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, reported that Daphne Zohar, founder and chief executive officer, will present at the Jefferies 2019 Healthcare Conference in New York City on Wednesday, June 5, at 11:30 AM EDT (Press release, PureTech Health, MAY 30, 2019, View Source [SID1234536669]). A webcast of the presentation will be available at View Source under the Reports and Presentations tab.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!